Navamedic News and Activities

Navamedic is a company listed under the stock ticker NAVA (NO).

Navamedic has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 28 main executives

Most searched biographies at Navamedic

• Kathrine Andreassen, Chief Executive Officer
• Jostein Davidsen, Chairman of the Board
• Edmée Steenken, Director

Popular executive movements at Navamedic

• Nils Ole Krekling will join the company as Chief Financial Officer on Jan. 1, 2026  (posted on December 8 2025).
• Lars Hjarrand, Chief Financial Officer, will leave the company in Jan. 2026  (posted on December 8 2025).

Create your alert
to follow the executive moves at Navamedic.

Navamedic has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Navamedic

• News archive - Navamedic
• Erhållen MDR-certifiering säkerställer kontinuitet av distribution för doseringsapparaten MyFID vid behandling av Parkinsons sjukdom | Navamedic
• Navamedic ASA: Invitation to 2022 4th quarter presentation | Navamedic

Social media about Navamedic

• Navamedic on Wikipedia, Google News & Yahoo Finance
• Navamedic on LinkedIn, X (Twitter) & YouTube